Journal Article


Karen L Furie
Megan Lederer
Elizabeth Stevenson
Hang Lee
Jane Hubbard
Ginger L Milne
Erin Terry
Eng H Lo
Walter Koroshetz
MingMing Ning
and 2 others


Medicine & Nursing

aged antioxidants brain ischemia middle aged severity of illness index oxidative stress physiology pharmacology alpha tocopherol aged 80 and over cerebral infarction f2 isoprostanes diffusion magnetic resonance imaging therapeutic use humans biological markers case control studies female matrix metalloproteinase 9 physiopathology pathology fibrinolytic agents treatment outcome ascorbic acid blood male stroke drug therapy tissue plasminogen activator

Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. (2007)

Abstract Experimental stroke studies indicate that oxidative stress is a major contributing factor to ischemic cerebral injury. Oxidative stress is also implicated in activation of matrix metalloproteinases (MMPs) and blood-brain barrier injury after ischemia-reperfusion. Plasma biomarkers of oxidative stress may have utility as early indicators of efficacy in Phase 2 trials of antioxidant therapies in human stroke. To date, a valid biomarker has been unavailable. We measured F2-isoprostanes (F2IPs), free-radical induced products of neuronal arachadonic acid peroxidation, in acute ischemic stroke. We aimed to determine the change in plasma F2IP levels over time and relationship with plasma MMP-9 in tPA-treated and tPA-untreated stroke patients. We performed a case-control study of consecutive ischemic stroke patients (25 tPA-treated and 27 tPA-untreated) presenting within 8 hours of stroke onset. Controls were individuals without prior stroke from a primary care clinic network serving the source population from which cases were derived. Infarct volume was determined on acute diffusion-weighted MRI (DWI) performed within 48 hours using a semi-automated computerized segmentation algorithm. Phlebotomy was performed at <8 hours, 24 hours, 2 to 5 days, and 4 to 6 weeks. F2IPs were measured by gas chromatography/mass spectrometry and MMP-9 by ELISA. Prestroke antioxidant dietary intake was measured by the 24-hour recall method. In 52 cases and 27 controls, early (median 6 hours postonset) F2IPs were elevated in stroke cases compared with controls (medians 0. 041 versus 0.0295 pg/mL, P=0.012). No difference in F2IPSs was present at later time points. Early plasma F2IPs correlated with MMP-9 in all patients (P=0.01) and the tPA-treated subgroup (P=0.02). No correlation was found with NIHSS, DWI infarct volume, 90-day Rankin score, or C-reactive protein (P>0.05 for all). In early human stroke we found evidence of increased oxidative stress and a relationship with MMP-9 expression, supporting findings from experimental studies.
Collections Ireland -> University College Dublin -> PubMed

Full list of authors on original publication

Karen L Furie, Megan Lederer, Elizabeth Stevenson, Hang Lee, Jane Hubbard, Ginger L Milne, Erin Terry, Eng H Lo, Walter Koroshetz, MingMing Ning and 2 others

Experts in our system